Effect of a six-month therapy with alfacalcidol on muscle power and balance and the number of fallers and falls.

Abstract

PURPOSE In an open observational prospective multicentered study on a cohort of patients with a creatinine clearance of < or = 65 ml/min and diagnosed with the "Esslinger Fall Risk Assessment" to be at an increased risk for falls the effect of daily treatment with 1 microg alfacalcidol (CAS 41294-56-8; Alpha-D3) on muscle power, balance and number of… (More)
DOI: 10.1055/s-0031-1296321

Topics

  • Presentations referencing similar topics